| In vitro and in vivo evaluation of ruthenium (II)− arene PTA complexes C Scolaro, A Bergamo, L Brescacin, R Delfino, M Cocchietto, G Laurenczy, ... Journal of medicinal chemistry 48 (12), 4161-4171, 2005 | 963 | 2005 |
| Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates A Bergamo, C Gaiddon, JHM Schellens, JH Beijnen, G Sava Journal of inorganic biochemistry 106 (1), 90-99, 2012 | 632 | 2012 |
| Ruthenium antimetastatic agents E Alessio, G Mestroni, A Bergamo, G Sava Current Topics in Medicinal Chemistry 4 (15), 1525-1535, 2004 | 610 | 2004 |
| Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs A Bergamo, G Sava Dalton Transactions 40 (31), 7817-7823, 2011 | 506 | 2011 |
| Dual action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen G Sava, S Zorzet, C Turrin, F Vita, MR Soranzo, G Zabucchi, M Cocchietto, ... Clinical Cancer Research 9 (5), 1898-1905, 2003 | 369 | 2003 |
| Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A G Sava, A Bergamo, S Zorzet, B Gava, C Casarsa, M Cocchietto, A Furlani, ... European Journal of Cancer 38 (3), 427-435, 2002 | 306 | 2002 |
| Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound A Bergamo, A Masi, PJ Dyson, G Sava International journal of oncology 33 (6), 1281-1289, 2008 | 285 | 2008 |
| Ruthenium complexes can target determinants of tumour malignancy A Bergamo, G Sava Dalton Transactions, 1267-1272, 2007 | 274 | 2007 |
| Metal-based antitumour drugs in the post-genomic era: what comes next? G Sava, A Bergamo, PJ Dyson Dalton Transactions 40 (36), 9069-9075, 2011 | 270 | 2011 |
| In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin A Bergamo, R Gagliardi, V Scarcia, A Furlani, E Alessio, G Mestroni, ... Journal of Pharmacology and Experimental Therapeutics 289 (1), 559-564, 1999 | 270 | 1999 |
| Linking the future of anticancer metal-complexes to the therapy of tumour metastases A Bergamo, G Sava Chemical Society Reviews 44 (24), 8818-8835, 2015 | 232 | 2015 |
| In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model A Bergamo, A Masi, AFA Peacock, A Habtemariam, PJ Sadler, G Sava Journal of inorganic biochemistry 104 (1), 79-86, 2010 | 224 | 2010 |
| Ruthenium-based compounds and tumour growth control G Sava, A Bergamo International journal of oncology 17 (2), 353-418, 2000 | 206 | 2000 |
| Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine. G Sava, R Gagliardi, A Bergamo, E Alessio, G Mestroni Anticancer research 19 (2A), 969-972, 1999 | 205 | 1999 |
| Sulfoxide ruthenium complexes: non-toxic tools for the selective treatment of solid tumour metastases G Sava, E Alessio, A Bergamo, G Mestroni Metallopharmaceuticals I: DNA Interactions, 143-169, 1999 | 198 | 1999 |
| Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A A Vacca, M Bruno, A Boccarelli, M Coluccia, D Ribatti, A Bergamo, ... British journal of cancer 86 (6), 993-998, 2002 | 195 | 2002 |
| Influence of hydrogen-bonding substituents on the cytotoxicity of RAPTA compounds C Scolaro, TJ Geldbach, S Rochat, A Dorcier, C Gossens, A Bergamo, ... Organometallics 25 (3), 756-765, 2006 | 193 | 2006 |
| Lack of in vitro cytotoxicity, associated to increased G2-M cell fraction and inhibition of matrigel invasion, may predict in vivo-selective antimetastasis activity of … S Zorzet, A Bergamo, M Cocchietto, A Sorc, B Gava, E Alessio, E Iengo, ... Journal of Pharmacology and Experimental Therapeutics 295 (3), 927-933, 2000 | 180 | 2000 |
| Synthesis, characterization and biological activity of copper complexes with pyridoxal thiosemicarbazone derivatives. X-ray crystal structure of three dimeric complexes MB Ferrari, F Bisceglie, G Pelosi, P Tarasconi, R Albertini, PP Dall’Aglio, ... Journal of inorganic biochemistry 98 (2), 301-312, 2004 | 153 | 2004 |
| Ruthenium anticancer drugs E Alessio, G Mestroni, A Bergamo, G Sava Metal Ions in Biological Systems 42, 323-352, 2004 | 149 | 2004 |
